Press Releases

Sepsis is a life-threatening condition that kills millions annually; it is poorly understood and has no specific treatment. Now, researchers from Tata Memorial Centre, India, led by Prof. Dr Indraneel Mittra, have uncovered an important molecular mechanism underlying different...

C2 PHARMA s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, is announcing that they will open access to safety stocks of the active pharmaceutical ingredient (API), Digoxin. In early March, the API was listed for...

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced that the U.S. FDA has provided Emergency Use Authorization (EUA) for the Company’s New Coronavirus RT-PCR test. Clinical laboratories certified under Clinical Laboratory Improvement Amendments (CLIA)...

Vir Biotechnology, Inc announced that it has identified multiple human monoclonal antibody (mAb) development candidates that neutralize SARS-CoV-2, the virus responsible for COVID-19. “We are pleased with the rapidity of our progress and excited to move two development candidates into...

Destiny Pharma , a clinical stage biotechnology company focused on the development of novel, hospital infection prevention treatments that address the global challenge of antimicrobial resistance (AMR), announces the completion of the initial phase of its project with MedPharm...

AbbVie announced the VIALE-A (M15-656) trial of Venetoclax in combination with azacitidine versus azacitidine in combination with placebo met its dual primary endpoints of statistically significant improvement of overall survival (OS) and composite complete remission rate (CR + CRi)...

Online payment company PayCargo has launched a free communication mechanism that allows vendors such as airlines, ship terminals, and maritime operators to share key information with the 20,000-plus payer users in the company’s online system. The service enables vendors to...